A talk with Salvatore Mascia, Founder & CEO, and Bayan Takizawa, Co-Founder and CBO, to recap the genesis of CONTINUUS Pharmaceuticals, a spin-out company from a multi-year collaboration between MIT and Novartis on Continuous Manufacturing. CONTINUUS Pharmaceuticals offers a breakthrough Integrated Continuous Manufacturing (ICM) technology for small molecules with the aim of improve affordability and accessibility of pharmaceuticals on a global scale. IMA Active is one of the major stakeholders inside CONTINUUS.

Discover more: www.continuuspharma.com

свернуть